^
    Back
    Association details:
    Biomarker:XPC K939G + XPC A499V
    Cancer:Chronic Myeloid Leukemia
    Drug:imatinib (YD312) (c-KIT inhibitor, SCF signal transduction pathway inhibitor)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C3 – Early Trials
    Source:
    J Gene Med
    Title:

    Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of Chronic Myeloid Leukemia: A case-control study in South Indian Population

    Published date:
    04/08/2021
    Excerpt:
    Significant association of Ala499Val and Lys939Gln polymorphisms with prognosis was observed (Hasford high risk, p= 0.031; 0.019)....Both polymorphisms studied are considered as genetic markers in assessing disease progression, therapy response and prognosis in CML patients
    DOI:
    10.1002/jgm.3339